Requests similar to 'Demographic data of patients suffering from CVST and Thrombocytopenia following COVID-19 AZ Vaccine'
Age range and sex distribution of post AZ vaccine CVST cases and fatalities
Response by Medicines and Healthcare Products Regulatory Agency to O. Sullivan on .
Awaiting classification
Dear Sir/ Madam,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division...
Age range and sex distribution of patients with thrombo-embolic events with concurrent thrombocytopenia cases post second dose AZ vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Joanna Rodgers on .
Awaiting classification
Dear Ms Rodgers,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines D...
SARS-CoV-2 virus spike proteins damage the lungs and arteries of an animal model.
Response by Medicines and Healthcare Products Regulatory Agency to Roland Gilmore on .
Long overdue
Dear Mr Gilmore,
RE: CSC 49802 & 48472 Freedom of Information request - SARS-CoV-2 virus
spike proteins damage the lungs and arteries of an anim...
Reports and Data to meet Conditions of Authorisation for Vaxzevria
Response by Medicines and Healthcare Products Regulatory Agency to CHP Gillow on .
Partially successful
Dear CHP Gillow
Please find attached the response to your delayed request FOI 23/105. Due
to the size of some of the attachments, I’ll send...
Covid19 Vaccination Programme - Risk-Benefit Evidence
Response by Medicines and Healthcare Products Regulatory Agency to Bob Parkinson on .
Long overdue
Internal Review of FOI 21/374
Dear Bob Parkinson,
Thank you for your email.
Please find attached the response to your Internal Review...
MHRA Internal communications relating to FOIA Request 23/105
Response by Medicines and Healthcare Products Regulatory Agency to CHP Gillow on .
Successful
Dear CHP Gillow
I am writing to provide the response to your request FOI/23 266, which
asked:
“I would be grateful if you could provide me...
June Raine emails
Response by Medicines and Healthcare Products Regulatory Agency to Barbara Jones on .
Partially successful
FOI 22/745
Dear Ms Jones,
Thank you for your email.
Please find attached the response and documents to your FOI request.
Yours sincerely
MHRA Cust...
Covid-19 Vaccination - Adverse Side effects- Blood Clots and Astra Zeneca
Response by Medicines and Healthcare Products Regulatory Agency to Mairead Price on .
Awaiting classification
Dear Ms Price,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Div...
Astrazeneca clot demographics
Response by Medicines and Healthcare Products Regulatory Agency to Vicky Thomson on .
Successful
Dear Ms. Thomson,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Divis...
AZ Vaxzevria Trial D8111C00004 (UK)
Response by Medicines and Healthcare Products Regulatory Agency to CHP Gillow on .
Successful
Dear CHP Gillow
Please find attached 3 disclosure documents for your request for
information on the AZ Vaxzevria Trial D8111C00004. These were a...
Public Assessment Report - Vaxzevria - post authorisation studies
Response by Medicines and Healthcare Products Regulatory Agency to CHP Gillow on .
Successful
FOI 22/931
Dear CHP Gillow,
Thank you for your email.
Please find attached response and additional document to your request.
Kind Regards
MHRA Cu...
Safety signal reporting for Pfizer/BioNTech Covid 19 Vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Mr B Kingsley on .
Partially successful
FOI 23/474
Dear Mr B Kingsley
Thank you for your email.
Please find attached the response and documentation to your FOI request.
Kind Regards
MHR...
AstraZeneca trial data
Response by Medicines and Healthcare Products Regulatory Agency to vikki spit on .
Awaiting classification
FOI 22/715
Dear Vikki Spit
Thank you for your email.
Regarding Q1, the clinical data for the AZ vaccine is available through the European Medicines...
PV Strategy Document, AESI spreadsheet, Pfizer case output files
Response by Medicines and Healthcare Products Regulatory Agency to D Jackson on .
Partially successful
Internal Review of FOI 22/912
Dear D Jackson,
Thank you for your email.
Please find attached the response and attached document to your Internal Rev...
Astra Zeneca adverse reactions: batch PV46674
Response by Medicines and Healthcare Products Regulatory Agency to E McLaren on .
Successful
FOI 24/163
Dear E McLaren,
Thank you for your email.
Please find attached a response to your FOI request.
Kind regards,
F...
A package Insert of Fluenz Tetra nasal spray flu vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Kristine Bondarenko on .
Partially successful
Dear Ms Bondarenko,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Safety & Surveillance Group
Medicines and Healthca...
Scientific evidence of SARS COVID 2 in humans
Response by Medicines and Healthcare Products Regulatory Agency to Andrew Sibley on .
Partially successful
FOI 23/074
Dear Mr Sibley,
Thank you for your email.
Regarding the below questions:
I would therefore ask to see your scientific evidence...
Our Ref: FOI 22/605
Dear Mr/Ms Jackson,
Please see the attached response to your enquiry.
Kind Regards,
MHRA...
Additional data provided regarding covid vaccines
Response by Medicines and Healthcare Products Regulatory Agency to Clare Craig on .
Refused
FOI 23/129
Dear Dr Clare Craig,
Thank you for your email.
Please note that regarding the data submitted to MHRA for the
authorisation, the...
Batch Query for Oxford Astra Zeneca vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Rebecca Campbell on .
Successful
Dear Rebecca Campbell,
I am writing in response to your request for information, received 8th
August.
Please find the response to your request att...
Immune system's response to pathogens following COVID-19 vaccination
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Refused
FOI 21/550
Dear Mr MacArthur
Thank you for your email.
The temporary authorisations of the Pfizer/BioNTech, Oxford/AstraZeneca
and M...
Error in yellow card report Cov-19 Astrazeneca
Response by Medicines and Healthcare Products Regulatory Agency to Joanna Rodgers on .
Awaiting classification
Dear Ms Rodgers,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines D...
Questions re vaccines
Response by Medicines and Healthcare Products Regulatory Agency to Sally Anne on .
Awaiting classification
Dear Ms O'Donnell,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division...
Internal Communication in respect of FOIA request 23/073
Response by Medicines and Healthcare Products Regulatory Agency to CHP Gillow on .
Successful
Dear CHP Gillow
And now sent to the correct whatdotheyknow request page!
Please see details of response below and attached.
Dear CHP...
Inventory of items submitted in support of Vaxzevria's Temporary and Conditional Marketing Authorisations
Response by Medicines and Healthcare Products Regulatory Agency to CHP Gillow on .
Awaiting classification
Dear CHP Gillow
I sincerely apologise for the delay in responding to your request FOI
23/265 and I am now writing to provide the response to...